Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 192406, 7 pages
http://dx.doi.org/10.1155/2015/192406
Research Article

MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors

1Department of Urology, Yale School of Medicine, New Haven, CT 06520-8058, USA
2Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520-8028, USA
3Department of Pathology, Yale University School of Medicine, New Haven, CT 06520-8023, USA

Received 16 January 2015; Accepted 8 April 2015

Academic Editor: Aurelio Ariza

Copyright © 2015 Brian Shuch et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Brian Shuch, Ryan Falbo, Fabio Parisi, et al., “MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors,” BioMed Research International, vol. 2015, Article ID 192406, 7 pages, 2015. https://doi.org/10.1155/2015/192406.